Information:
Error:
ID
28997
Description
A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.
Keywords
Versions (1)
- 2/20/18 2/20/18 -
Copyright Holder
GlaxoSmithKline (GSK)
Uploaded on
February 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518
Visit1 Informed consent and Demographics
- StudyEvent: ODM
Similar models
Visit1 Informed consent and Demographics
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Default Itemgroup
C0021430 (UMLS CUI-1)
C0011298 (UMLS CUI-3)
C0011298 (UMLS CUI-3)
Informed consent
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
C0021430 (UMLS CUI [1])
Centre number
Item
Centre number
integer
C2825181 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,2])
date of birth
Item
date of birth
date
C0421451 (UMLS CUI [1])
CL Item
Male ([M])
CL Item
Female ([F])
CL Item
Black (1)
(Comment:en)
CL Item
Arabic/North African (2)
(Comment:en)
CL Item
White/Caucasian (3)
(Comment:en)
CL Item
East & South East Asian (4)
(Comment:en)
CL Item
South Asian (5)
(Comment:en)
CL Item
American Hispanic (6)
(Comment:en)
CL Item
Japanese (7)
(Comment:en)
CL Item
Other, please specify (8)
(Comment:en)
No comments